Coronavirus Antigen Testing Gets Green Light In Germany

Boost for testing volumes and Paul-Ehrlich-Institut role gets industry support

Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.

Paul Ehrlich Institut

Antigen tests for COVID-19 have so far not been part of Germany’s COVID-19 testing strategy, but that will change on 15 October, to add more firepower to the PCR testing regime as the winter flu season kicks in.

Germany’s COVID-19 incidence rate has been rising, as lockdown measures have been eased and people have returned from overseas holidays,...

More from Diagnostics

More from Device Area

With CMS Coverage Established, Medtronic Looks To Next Steps For Renal Denervation

 
• By 

US Medicare has proposed national coverage of renal denervation for patients with uncontrolled hypertension. The treatment is seeing other advances as well, with Medtronic piloting a longer catheter and a multi-organ approach and a blood test to identify the best candidates fresh on the

PFA Market Surges As UK NICE Opens Doors And US FDA Approves Boston, J&J Incremental Innovations

 

The pulsed-field ablation market is surging, with the UK NHS opening doors and FDA updates for major players. Medtech Insight spoke with Steven Mickelsen, founder of Farapulse (the first clinically approved PFA system), about the sector's growth and his new venture, Field Medical.

CDX Medical Technologies Secures $2.5M To Advance Smart ECMO Platform Toward FDA Approval

 
• By 

CDX is eying applications for its pump platform that go beyond ECMO. The company’s CEO says smart pumps that can be fine-tuned to patient volume and configuration are needed, and CDX is creating a scalable solution capable of supporting both acute and chronic lung care.